FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/054162 [Registered on: 20/06/2023] Trial Registered Prospectively
Last Modified On: 17/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Role Of Homoeopathy In Treatment Of Primary Dysmenorrhea 
Scientific Title of Study   Usefulness of Individualized Homoeopathic Medicine Along With Miasmatic Approach And Lifestyle Management In Primary Dysmenorrhea - Randomized controlled Study. 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Anju Singh 
Designation  PG Scholar 
Affiliation  Bakson Homoeopathic Medical College Greater Noida 
Address  Department Of Organon of Medicine Room no S1 Second Floor Bakson Homoeopathic Medical College And Hospital 36 B Knowledge Park Phase 1
Nil
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9026145849  
Fax    
Email  dr.anjusingh28@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Anju Singh 
Designation  PG Scholar 
Affiliation  Bakson Homoeopathic Medical College Greater Noida 
Address  Department Of Organon of Medicine Room no S1 Second Floor Bakson Homoeopathic Medical College And Hospital 36 B Knowledge Park Phase 1
Nil
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9026145849  
Fax    
Email  dr.anjusingh28@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Anuroopam Swami 
Designation  Professor 
Affiliation  Bakson Homoeopathic Medical College And Hospital 
Address  Department Of Organon of Medicine Room no S1 Second Floor Bakson Homoeopathic Medical College And Hospital36 B Knowledge Park Phase 1
Nil
Gautam Buddha Nagar
UTTAR PRADESH
201310
India 
Phone  9868954687  
Fax  -  
Email  anuroopam@gmail.com  
 
Source of Monetary or Material Support  
Bakson Homeopathic Medical College and Hospital 
 
Primary Sponsor  
Name  Bakson Homeopathic Medical College and Hospital 
Address  Room No G22 Ground Floor Bakson Homeopathic Medical College and Hospital  
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
Nil  Not Applicable 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Anju Singh  Bakson Homoeopathic Medical College and Hospital  Room No 1 Ground Floor OPD Bakson Homeopathic Medical College and Hospital 36 B Knowledge park 1 Greater Noida Gautam Buddha Nagar
Gautam Buddha Nagar
UTTAR PRADESH 
9026145849

dr.anjusingh28@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee Bakson Homeopathic Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N944||Primary dysmenorrhea,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Individualised Homoeopathic Medicine  Oral Route of Administration Pill Form 30 Pill Size Centesimal Scale Prescribed at the start of treatment. Repetition according to follow ups. Follow ups every 4 weeks 
Comparator Agent  Nil  Not Applicable 
Intervention  Placebo  Oral Route of Administration Pill Form 30 Pill Size Centesimal Scale Prescribed at the start of treatment. Repetition according to follow ups. Follow ups every 4 weeks 
 
Inclusion Criteria  
Age From  10.00 Year(s)
Age To  19.00 Year(s)
Gender  Female 
Details  1 Patient between 10 years to 19 years for the adolescent age group
2 Pain occurring since menarche as well as pre menopause
3 Clinical features of primary dysmenorrhea must be present during most menstrual cycles which includes pain arising on the first day of menses spasmodic pain and confined to the lower abdomen This pain may radiate to the back and middle aspect of the thigh
4 Those having mild or moderate dysmenorrhea
5 Patients with a regular menstrual cycle of 21-35 days 
 
ExclusionCriteria 
Details  1 patients with regular menstrual cycles of more than 35 days or less than 21 days
2 patients taking any other treatment for any other complaints
3 patient with any other pelvic disease leading to secondary dysmenorrhea sech as fibroid PCOD endometriosis Pelvic Inflammatory Diseases
4 Pregnant and lactating women  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Expected reduction in VRS scale  VRS scale will be used at baseline, 4 weeks, 8 weeks, 12 weeks etc 
 
Secondary Outcome  
Outcome  TimePoints 
Expected reduction in WaLLID Score   WaLLID score will be done at baseline, 4 weeks, 8 weeks, 12 weeks etc 
 
Target Sample Size   Total Sample Size="72"
Sample Size from India="72" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/07/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="3"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Study aims to evaluate the effectiveness of individualised homoeopathic treatment and placebo effects in cases of primary dysmenorrhea
VRS scale will be used to assess the level of pain at the baseline and then every month.
WaLLID scale will be used to assess the daily routine activities of patients with primary dysmenorrhea.  
 
Close